Edelris

MedChem CRO specialized in the design, synthesis & screening of unique & innov. NP-mimetic screening compound libraries
(+2M cmps), HTL & LO MedChem projects

[Edelris @edelris]

2nd Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery / Virtual Event - June 8-9, 2022 https://t.co/vsOep2E1X0

[Société de Chimie Thérapeutique @SCT_asso]

5 positions available @edelris Lyon:
1/ Senior Research Scientist in #MedicinalChemistry
2/ Research Scientist in Org Chemistry
3/ Technician in Org Chemistry
4/ Senior Research Scientist in #Biochemistry
5/ Research Scientist in Biochemistry
contact [email protected]
@SCT_asso

[BioSolveIT @biosolveit]

#ChemJobs — Our friends at @Edelris in beautiful++ Lyon have 2 very attractive senior positions on their freshly made carreers site: https://t.co/IEY8wuySNS

Feel free to RT
@MedicinalChemistry
@Biochemistry
@villedelyon

[Edelris @edelris]

1st Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery / Virtual Event - June 2-3 https://t.co/qdAlSLONuI

[Edelris @edelris]

We are pleased to share our recent publication in @nresearchnews about Affinity Selection-Mass Spectrometry which is an integrated part of our #drugdiscovery services and relies upon our unique 1.5M Natural product-like compound library.
#medchem
https://t.co/0BTdQP2gwb

[Edelris @edelris]

With the arrival of Mark Wever as a PhD candidate, the @HelixAnti team of Edelris is now ready to perform cutting-edge science!

[Edelris @edelris]

Celebrating International Women’s Day is a great opportunity to shine a light on the women that make up 50% of our team. #WomenInScience #GenderEqual #IWD2020 #EachforEqual

[Edelris @edelris]

Edelris and @GalapagosNV announce extension of a multi‐year research agreement https://t.co/EcbiWam38N

[Edelris @edelris]

Pioneering for the past 15 years natural product-like libraries for hit generation
https://t.co/zZi7FiSKdY

[Edelris @edelris]

Edelris and Max Planck insitute announce a Research Collaboration aiming the identification of novel ligands towards groundbreaking biological targets.

[Edelris @edelris]

In February, we will be celebrating Edelris’ 15th anniversary. It is a great occasion to go through old pictures and see that from 2005 to 2020, things have changed a little!

[Edelris @edelris]

At Edelris we prepare innovative #DNAEncodedLibraries for our customers. The combination of our unique 3D Keymical™ Building blocks with state-of-the-art equipment allows for the fast preparation of millions of compounds barcoded with DNA.

[Edelris @edelris]

We are pleased to announce the appointment of Delphine Barthes as Head of Operations. https://t.co/EcbiWam38N

[Edelris @edelris]

We are looking for an inside sales representative. Check our offer and seize the opportunity to work with our team! #apply #jobopening #jobopportunity https://t.co/EcbiWam38N

[Edelris @edelris]

A great opportunity for us to host a PhD starting end of February 2020!

[AntiHelix Project @anti_helix]

And we will soon contribute with our 13 ESRs!

[Edelris @edelris]

Efficient preparation of building blocks is essential in libraries production. Application of continuous-flow technology in photochemistry processes allows us to prepare starting materials for our Keymical Collections™ on multigram scale!

[Edelris @edelris]

At Edelris we have our own way of participating to the #festivaloflights this year!
#Photochemistry #FDL2019 #FetedesLumieres

[Edelris @edelris]

Didier Roche (VP Strategic Innovation) présentera notre expertise dans la conception de librairies de molécules Natural by design™pour la génération de hit lors de la 1ere rencontre Drug Discovery in Oncolongy le 4 décembre à Lyon @canceroCLARA

[AntiHelix Project @anti_helix]

Official start of the MSCA-ITN AntiHelix project at the kick off meeting in Copenhagen, on the 4th of October 2019. #MSCA #ITN @MSCActions

[Edelris @edelris]

Another success achieved using 3D compounds from our Keymical Collections™! Check the recent breakthrough discovery and optimization of GLUT-1 & -3 inhibitors done by Prof. H.Waldmann at the Max-Planck Institute https://t.co/1KCGSwNDha